Additional treatments, such as intravitreal injection of anti-VEGF drugs or early vitreous surgery, need to be addressed for AP-ROP in large preterm infants as well as in small preterm infants [24–26]. This evidence concerns the gene VEGFA and retinopathy of prematurity.